Artezio will take part in BioPartnering BioNJ along with such companies as JP Morgan and Johnson & Johnson. The conference will be held virtually and offer attendees the unique experience of virtual partnership, in addition to access to presentations and opportunities to talk to speakers.
Today, US businesses are actively developing digital platforms for effective communication between event participants. Organizers of industry specific conferences try to compensate for a major drawback of online events – the challenge of making long term contacts and securing personal meetings with fellow attendees. For the IT sector, platforms such as BioPartnering BioNJ have been and still remain to be a very important interaction tool.
Even before the start of the pandemic and restrictions imposed due to Covid-19, special events allowed IT companies to find partners and customers in various fields. It also moved forward the progress and implementation of advanced technologies not only in the US, but across the globe.
The pandemic has altered the means of communication that existed before, spurring the creation of new tools for interaction. Since the demand for automation solutions is constantly growing, businesses in the US are interested in renewing communication between IT and businesses.
BioNJ’s 11th Annual BioPartnering Conference is a key event in the US that will allow software developers and their customers to recommence the dialogue around innovation and healthcare. Attendees just need to register to set up a meeting, proving that the platform can help resume one on one meetings that were popular before the pandemic. The conference focuses on biotechnology and healthcare—two important spheres that can help humanity overcome challenges caused by the pandemic.
“We are happy to get back to a format that allows for direct communication between partners and representatives of big enterprises in the US. A large number of those wishing to discuss the possibility of implementing real projects proves how important it is to find personal contacts,” Artezio’s representatives say.
The organizers of BioPartnering BioNJ believe that science has been, and still remains to be, the driving force behind healthcare development. Therefore, innovation should find its place throughout the US, including New Jersey where BioPartnering BioNJ is traditionally held.